Why the study?
Therapy for atrial fibrillation has markedly evolved over the past two decades, with technological advancements and growing therapeutic options warranting a reexamination of current evidence and updated guidelines.
This review summarizes contemporary evidence and updated guidelines supporting catheter ablation as a first-line therapy for selected patients with atrial fibrillation.
Answers are grounded in this paper and cite their sources.
May support earlier ablation consideration in selected AF; leaves open need for prospective RCTs to guide practice.
Therapy for atrial fibrillation has markedly evolved over the past two decades. Advancements in technology and growing therapeutic options have led to reexamination of the current evidence. New guidelines have also been updated and published across continents. This reappraisal of the contemporary data assesses the overall treatment strategies for patients with atrial fibrillation, and examines how atrial fibrillation ablation ranks among the hierarchy of therapeutic modalities. The role of catheter ablation as a first-line therapy in selected patients with atrial fibrillation is emphasized, and a selective discussion of catheter ablation in patients with heart failure is included in this review.
No takes yet. Share an insight, caveat, or question.
Fatunde et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: